Related references
Note: Only part of the references are listed.Cardiometabolic outcomes among schizophrenia patients using antipsychotics: the impact of high weight gain risk vs low weight gain risk treatment
Rezaul Khandker et al.
BMC PSYCHIATRY (2022)
A randomized trial shows dose-frequency and genotype may determine the therapeutic efficacy of intranasal oxytocin
Juan Kou et al.
PSYCHOLOGICAL MEDICINE (2022)
Metabolic Syndrome: Updates on Pathophysiology and Management in 2021
Gracia Fahed et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)
Heterogeneity in response to repeated intranasal oxytocin in schizophrenia and autism spectrum disorders: A meta-analysis of variance
Daniel Martins et al.
BRITISH JOURNAL OF PHARMACOLOGY (2022)
Evidence for Schizophrenia-Specific Pathophysiology of Nicotine Dependence
Heather Burrell Ward et al.
FRONTIERS IN PSYCHIATRY (2022)
Insulin Resistance: From Mechanisms to Therapeutic Strategies
Shin-Hae Lee et al.
DIABETES & METABOLISM JOURNAL (2022)
Childhood trauma, the stress response and metabolic syndrome: A focus on DNA methylation
Jacqueline S. Womersley et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2022)
The Influence of Oxytocin and Prolactin During a First Episode of Psychosis: The Implication of Sex Differences, Clinical Features, and Cognitive Performance
Maria Hidalgo-Figueroa et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2022)
Adiponectin, leptin and resistin levels in first-episode, drug-naive patients with psychosis before and after short-term antipsychotic treatment
Petros Petrikis et al.
JOURNAL OF PSYCHOSOMATIC RESEARCH (2022)
Orexin-a elevation in antipsychotic-treated compared to drug-free patients with schizophrenia: A medication effect independent of metabolic syndrome
Po -Yu Chen et al.
JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION (2022)
Peripheral oxytocin concentrations in psychiatric disorders - A systematic review and methanalysis: Further evidence
Adriana Colar Ferreira et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2022)
The importance of pro-social processing, and ameliorating dysfunction in schizophrenia. An FMRI study of oxytocin
Rebekah Wigton et al.
SCHIZOPHRENIA RESEARCH-COGNITION (2022)
Epigenetic Modifications in Schizophrenia and Related Disorders: Molecular Scars of Environmental Exposures and Source of Phenotypic Variability
Juliet Richetto et al.
BIOLOGICAL PSYCHIATRY (2021)
Oxytocin Signaling Pathway: From Cell Biology to Clinical Implications
Michele Iovino et al.
ENDOCRINE METABOLIC & IMMUNE DISORDERS-DRUG TARGETS (2021)
Gut microbiota in human metabolic health and disease
Yong Fan et al.
NATURE REVIEWS MICROBIOLOGY (2021)
Associations between hemispheric asymmetry and schizophrenia-related risk genes in people with schizophrenia and people at a genetic high risk of schizophrenia
Yue Zhu et al.
BRITISH JOURNAL OF PSYCHIATRY (2021)
Oxytocin in young children with Prader-Willi syndrome: Results of a randomized, double-blind, placebo-controlled, crossover trial investigating 3 months of oxytocin
Layla Damen et al.
CLINICAL ENDOCRINOLOGY (2021)
Altered hormonal and autonomic nerve responses to hypo- and hyperglycaemia are found in overweight and insulin-resistant individuals and may contribute to the development of type 2 diabetes
Martin H. Lundqvist et al.
DIABETOLOGIA (2021)
Mechanisms Underlying the Comorbidity of Schizophrenia and Type 2 Diabetes Mellitus
Yutaka Mizuki et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2021)
Reconstruction of the Hypothalamo-Neurohypophysial System and Functional Dissection of Magnocellular Oxytocin Neurons in the Brain
Bin Zhang et al.
NEURON (2021)
Role of Oxytocin and Vasopressin in Neuropsychiatric Disorders: Therapeutic Potential of Agonists and Antagonists
Valeska Cid-Jofre et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Association of Adverse Childhood Experiences With Cardiovascular Disease Later in Life A Review
Lucas C. Godoy et al.
JAMA CARDIOLOGY (2021)
Preliminary evidence that oxytocin does not improve mentalizing in women with schizophrenia
Ellen R. Bradley et al.
HORMONES AND BEHAVIOR (2021)
Oxytocin in Schizophrenia: Pathophysiology and Implications for Future Treatment
Kah Kheng Goh et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Adipokines, Myokines, and Hepatokines: Crosstalk and Metabolic Repercussions
Ana Rita de Oliveira dos Santos et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Effects of Oxytocin on Emotion Recognition in Schizophrenia A Randomized Double-Blind Pilot Study
Elissar Andari et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2021)
Glucagon-like peptide-1 serum levels are associated with weight gain in patients treated with clozapine
Jari-Pekka Klemettila et al.
PSYCHIATRY RESEARCH (2021)
Cardiovascular disease and mortality in people with schizophrenia or antipsychotic treatment: A cohort study in primary care
Miguel Castillo Sanchez et al.
PSYCHIATRY RESEARCH (2021)
The prevalence and clinical correlates of metabolic syndrome and cardiometabolic alterations in 430 drug-naive patients in their first episode of schizophrenia
Xiaoe Lang et al.
PSYCHOPHARMACOLOGY (2021)
Prolactin levels influenced by antipsychotic drugs in schizophrenia: A systematic review and network meta-analysis
Yikang Zhu et al.
SCHIZOPHRENIA RESEARCH (2021)
A longitudinal study over 40 years to study the metabolic syndrome as a risk factor for cardiovascular diseases
Lars Lind et al.
SCIENTIFIC REPORTS (2021)
Identification of Common Pathogenetic Processes between Schizophrenia and Diabetes Mellitus by Systems Biology Analysis
Md Rezanur Rahman et al.
GENES (2021)
Atypical Antipsychotics and Metabolic Syndrome: From Molecular Mechanisms to Clinical Differences
Marco Carli et al.
PHARMACEUTICALS (2021)
Oxytocin-pathway polygenic scores for severe mental disorders and metabolic phenotypes in the UK Biobank
Adriano Winterton et al.
TRANSLATIONAL PSYCHIATRY (2021)
Metabolic Syndrome and Cognitive Function
Mouna Tahmi et al.
CURRENT CARDIOLOGY REPORTS (2021)
The type 2 diabetes mellitus susceptibility gene CDKAL1 polymorphism is associated with depressive symptom in first-episode drug-naive schizophrenic patients
Xu Yuan Yin et al.
HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL (2021)
The Candidate Schizophrenia Risk Gene Tmem108 Regulates Glucose Metabolism Homeostasis
Jianbo Yu et al.
FRONTIERS IN ENDOCRINOLOGY (2021)
Intranasal oxytocin for Negative Symptoms of Schizophrenia: Systematic Review, Meta-Analysis, and Dose-Response Meta-Analysis of Randomized Controlled Trials
Michel Sabe et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2021)
Metabolic disturbances associated with antipsychotic drug treatment in patients with schizophrenia: State-of-the-art and future perspectives
Shen-Chieh Chang et al.
WORLD JOURNAL OF PSYCHIATRY (2021)
Galectin-3 possible involvement in antipsychotic-induced metabolic changes of schizophrenia: A minireview
Milica M. Borovcanin et al.
WORLD JOURNAL OF DIABETES (2021)
Metabolic syndrome and cognitive performance across the adult lifespan
Lori Haase Alasantro et al.
PLOS ONE (2021)
Changes of Hypocretin (Orexin) System in Schizophrenia: From Plasma to Brain
Jing Lu et al.
SCHIZOPHRENIA BULLETIN (2021)
Leptin and Obesity: Role and Clinical Implication
Milan Obradovic et al.
FRONTIERS IN ENDOCRINOLOGY (2021)
Autonomic nervous system dysfunction in schizophrenia: impact on cognitive and metabolic health
Nicolette Stogios et al.
NPJ SCHIZOPHRENIA (2021)
Effects of intranasal oxytocin in food intake and craving: A meta-analysis of clinical trials
Chi-Ying Chen et al.
CLINICAL NUTRITION (2021)
Gut microbiota and microbiome in schizophrenia
Jerzy Samochowiec et al.
CURRENT OPINION IN PSYCHIATRY (2021)
A meta-analysis of blood and salivary cortisol levels in first-episode psychosis and high-risk individuals
Blazej Misiak et al.
FRONTIERS IN NEUROENDOCRINOLOGY (2021)
The Effects of Oxytocin on Appetite Regulation, Food Intake and Metabolism in Humans
Liya Kerem et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Oxytocin system dysfunction in patients with treatment-resistant schizophrenia: Alterations of blood oxytocin levels and effect of a genetic
Yusuke Nakata et al.
JOURNAL OF PSYCHIATRIC RESEARCH (2021)
Oxytocin levels in individuals with schizophrenia are high in cerebrospinal fluid but low in serum: A systematic review and meta-analysis Oxytocin and Schizophrenia
Yazmin Hernandez-Diaz et al.
METABOLIC BRAIN DISEASE (2021)
The effect of amisulpride, olanzapine, quetiapine, and aripiprazole single administration on c-Fos expression in vasopressinergic and oxytocinergic neurons of the rat hypothalamic paraventricular nucleus
Alexander Kiss et al.
NEUROPEPTIDES (2021)
Metabolic syndrome in antipsychotic-naive patients with first-episode psychosis: a systematic review and meta-analysis
Nathalia Garrido-Torres et al.
PSYCHOLOGICAL MEDICINE (2021)
Unveiling the Metabolic Profile of First-Episode Drug-Naive Schizophrenia Patients: Baseline Characteristics of a Longitudinal Study Among Han Chinese
Qi Zhang et al.
FRONTIERS IN PSYCHIATRY (2021)
Do Leptin Play a Role in Metabolism-Related Psychopathological Symptoms?
Yelei Zhang et al.
FRONTIERS IN PSYCHIATRY (2021)
Association Between ApoA1 Gene Polymorphisms and Antipsychotic Drug-Induced Dyslipidemia in Schizophrenia
Lin Fan et al.
NEUROPSYCHIATRIC DISEASE AND TREATMENT (2021)
Childhood trauma and cardiometabolic risk in severe mental disorders: The mediating role of cognitive control
Synve Hoffart Lunding et al.
EUROPEAN PSYCHIATRY (2021)
Metabolic syndrome components moderate the association between executive function and functional connectivity in the default mode network
Janelle T. Foret et al.
BRAIN IMAGING AND BEHAVIOR (2021)
Contribution of Components of Metabolic Syndrome to Cognitive Performance in Middle-Aged Adults
Karamfil M. Bahchevanov et al.
ARCHIVES OF CLINICAL NEUROPSYCHOLOGY (2021)
Brain insulin action in schizophrenia: Something borrowed and something new
Sri Mahavir Agarwal et al.
NEUROPHARMACOLOGY (2020)
Glucose disturbances, cognitive deficits and white matter abnormalities in first-episode drug-naive schizophrenia
Xiangyang Zhang et al.
MOLECULAR PSYCHIATRY (2020)
Oxytocin reduces the functional connectivity between brain regions involved in eating behavior in men with overweight and obesity
Liya Kerem et al.
INTERNATIONAL JOURNAL OF OBESITY (2020)
The role of oxytocin in regulation of appetitive behaviour, body weight and glucose homeostasis
Elizabeth A. Lawson et al.
JOURNAL OF NEUROENDOCRINOLOGY (2020)
Relationship between metabolic syndrome and acylated/desacylated ghrelin ratio in patients with schizophrenia under olanzapine medication
Tzu-Hua Wu et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2020)
Oxytocin Enhances an Amygdala Circuit Associated With Negative Symptoms in Schizophrenia: A Single-Dose, Placebo-Controlled, Crossover, Randomized Control Trial
Samantha Abram et al.
SCHIZOPHRENIA BULLETIN (2020)
Metabolic Effects of Oxytocin
Shana E. McCormack et al.
ENDOCRINE REVIEWS (2020)
Leptin and psychiatric illnesses: does leptin play a role in antipsychotic-induced weight gain?
Francky Teddy Endomba et al.
LIPIDS IN HEALTH AND DISEASE (2020)
Chronic oxytocin administration as a tool for investigation and treatment: A cross-disciplinary systematic review
Marilyn Horta et al.
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2020)
Childhood trauma and glucose metabolism in patients with first-episode psychosis
Sarah Tosato et al.
PSYCHONEUROENDOCRINOLOGY (2020)
Methylation of glucocorticoid receptor (NR3C1), BDNF and oxytocin receptor genes in association with childhood maltreatment in schizophrenia and schizoaffective disorder
V. Barker et al.
SCHIZOPHRENIA RESEARCH (2020)
20-year follow-up study of physical morbidity and mortality in relationship to antipsychotic treatment in a nationwide cohort of 62,250 patients with schizophrenia (FIN20)
Heidi Taipale et al.
WORLD PSYCHIATRY (2020)
Dietary Behaviors and Metabolic Syndrome in Schizophrenia Patients
Katarzyna Adamowicz et al.
JOURNAL OF CLINICAL MEDICINE (2020)
An Allostatic Theory of Oxytocin
Daniel S. Quintana et al.
TRENDS IN COGNITIVE SCIENCES (2020)
Physiological Effect of Ghrelin on Body Systems
Yonas Akalu et al.
INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (2020)
Cumulative Risk on Oxytocin-Pathway Genes Impairs Default Mode Network Connectivity in Trauma-Exposed Youth
Maor Zeev-Wolf et al.
FRONTIERS IN ENDOCRINOLOGY (2020)
Integrated Analysis of Summary Statistics to Identify Pleiotropic Genes and Pathways for the Comorbidity of Schizophrenia and Cardiometabolic Disease
Hao Liu et al.
FRONTIERS IN PSYCHIATRY (2020)
Biomarkers in Psychiatry: Concept, Definition, Types and Relevance to the Clinical Reality
Maria Salud Garcia-Gutierrez et al.
FRONTIERS IN PSYCHIATRY (2020)
Assessment of Appetite-Regulating Hormones Provides Further Evidence of Altered Adipoinsular Axis in Early Psychosis
Michal Lis et al.
FRONTIERS IN PSYCHIATRY (2020)
Oxytocin Controls Chondrogenesis and Correlates with Osteoarthritis
Christian H. Roux et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Trends in the Prevalence of Metabolic Syndrome in the United States, 2011-2016
Grishma Hirode et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
The polygenic architecture of schizophrenia - rethinking pathogenesis and nosology
Olav B. Smeland et al.
NATURE REVIEWS NEUROLOGY (2020)
Exogenous effects of oxytocin in five psychiatric disorders: a systematic review, meta-analyses and a personalized approach through the lens of the social salience hypothesis
Leehe Peled-Avron et al.
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2020)
Glucose homeostasis in unaffected first-degree relatives of schizophrenia patients: A systematic review and meta-analysis
Blazej Misiak et al.
SCHIZOPHRENIA RESEARCH (2020)
Interactome overlap between schizophrenia and cognition
Elise Koch et al.
SCHIZOPHRENIA RESEARCH (2020)
Oxytocin enhances the recovery of eye-contact induced autonomic arousal: A treatment mechanism study with placebo-controlled design
Nicky Daniels et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2020)
Effect of AUTS2 gene rs6943555 variant in male patients with schizophrenia in a Turkish population
Filiz Ozsoy et al.
GENE (2020)
The role of oxytocin and vasopressin dysfunction in cognitive impairment and mental disorders
Olga Abramova et al.
NEUROPEPTIDES (2020)
Is Oxytocin Nature's Medicine?
C. Sue Carter et al.
PHARMACOLOGICAL REVIEWS (2020)
Impaired hormonal regulation of appetite in schizophrenia: A narrative review dissecting intrinsic mechanisms and the effects of antipsychotics
Michal Lis et al.
PSYCHONEUROENDOCRINOLOGY (2020)
Risk Factors of Metabolic Syndrome in Community-Dwelling People with Schizophrenia
Min Jung Sun et al.
INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH (2020)
The Relationship of Functional Status of Cortisol, Testosterone, and Parameters of Metabolic Syndrome in Male Schizophrenics
Yi Han et al.
BIOMED RESEARCH INTERNATIONAL (2020)
Impact of Psychotropic Medication Effects on Obesity and the Metabolic Syndrome in People With Serious Mental Illness
Victor Mazereel et al.
FRONTIERS IN ENDOCRINOLOGY (2020)
Cardiometabolic Risk in First Episode Psychosis Patients
Jo Smith et al.
FRONTIERS IN ENDOCRINOLOGY (2020)
Central oxytocin signaling inhibits food reward-motivated behaviors and VTA dopamine responses to food-predictive cues in male rats
Clarissa M. Liu et al.
HORMONES AND BEHAVIOR (2020)
Childhood Trauma and Psychosis: An Updated Review
Kate J. Stanton et al.
CHILD AND ADOLESCENT PSYCHIATRIC CLINICS OF NORTH AMERICA (2020)
The role of schizotypal traits and the OXTR gene in theory of mind in schizophrenia: A family-based study
M. Giralt-Lopez et al.
EUROPEAN PSYCHIATRY (2020)
Impaired insulin signaling in unaffected siblings and patients with first-episode psychosis
Virginie-Anne Chouinard et al.
MOLECULAR PSYCHIATRY (2019)
Is psychosis a multisystem disorder? A meta-review of central nervous system, immune, cardiometabolic, and endocrine alterations in first-episode psychosis and perspective on potential models
Toby Pillinger et al.
MOLECULAR PSYCHIATRY (2019)
Intranasal oxytocin fails to acutely improve glucose metabolism in obese men
Swantje Brede et al.
DIABETES OBESITY & METABOLISM (2019)
Orexin-A Levels in Relation to the Risk of Metabolic Syndrome in Patients with Schizophrenia Taking Antipsychotics
Po-Yu Chen et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2019)
Oxytocin differentially modulates specific dorsal and ventral striatal functional connections with frontal and cerebellar regions
Zhiying Zhao et al.
NEUROIMAGE (2019)
Oxytocin in metabolic homeostasis: implications for obesity and diabetes management
C. Ding et al.
OBESITY REVIEWS (2019)
The effects of combined oxytocin and cognitive behavioral social skills training on social cognition in schizophrenia
Gregory P. Strauss et al.
PSYCHOLOGICAL MEDICINE (2019)
Loneliness in psychotic illness and its association with cardiometabolic disorders
Johanna C. Badcock et al.
SCHIZOPHRENIA RESEARCH (2019)
Prolactin levels in drug-naive first episode nonaffective psychosis patients compared with healthy controls. Sex differences
N. Del Cacho et al.
PSYCHIATRY RESEARCH (2019)
Endogenous oxytocin levels are associated with impaired social cognition and neurocognition in schizophrenia
Gregory P. Strauss et al.
JOURNAL OF PSYCHIATRIC RESEARCH (2019)
Increased levels of serum leptin in the early stages of psychosis
Lourdes Martorell et al.
JOURNAL OF PSYCHIATRIC RESEARCH (2019)
Neural and behavioral effects of oxytocin administration during theory of mind in schizophrenia and controls: a randomized control trial
Lize De Coster et al.
NEUROPSYCHOPHARMACOLOGY (2019)
Association of Insulin Resistance With Schizophrenia Polygenic Risk Score and Response to Antipsychotic Treatment
Jakub Tomasik et al.
JAMA PSYCHIATRY (2019)
Therapeutic Potential of Oxytocin in Atherosclerotic Cardiovascular Disease: Mechanisms and Signaling Pathways
Ping Wang et al.
FRONTIERS IN NEUROSCIENCE (2019)
Clinical Correlates of Insulin Resistance in Chronic Schizophrenia: Relationship to Negative Symptoms
Virawudh Soontornniyomkij et al.
FRONTIERS IN PSYCHIATRY (2019)
Decreased Serum Oxytocin and Increased Homocysteine in First-Episode Schizophrenia Patients
Yong Liu et al.
FRONTIERS IN PSYCHIATRY (2019)
Comparative efficacy and tolerability of 32 oral antipsychotics for the acute treatment of adults with multi-episode schizophrenia: a systematic review and network meta-analysis
Maximilian Huhn et al.
LANCET (2019)
Appetite regulating hormones in first-episode psychosis: A systematic review and meta-analysis
Blazej Misiak et al.
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2019)
Brain Angiotensinergic Regulation of the Immune System: Implications for Cardiovascular and Neuroendocrine Responses
Michele Iovino et al.
Endocrine Metabolic & Immune Disorders-Drug Targets (2019)
The relationship between serum adiponectin levels, cardiometabolic indices and metabolic syndrome in schizophrenia
Yi Hang Tay et al.
ASIAN JOURNAL OF PSYCHIATRY (2019)
Association of oxytocin levels and oxytocin receptor gene polymorphism (rs2254298) with cardiovascular risk factors in Brazilian elderly from Primary Health Care
Camila Bittencourt Jacondino et al.
ARCHIVES OF GERONTOLOGY AND GERIATRICS (2019)
Circulating Oxytocin Is Genetically Determined and Associated With Obesity and Impaired Glucose Tolerance
Mark Florian Joachim Weingarten et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2019)
Associations of oxytocin with metabolic parameters in obese women of childbearing age
Du Fu-Man et al.
ENDOKRYNOLOGIA POLSKA (2019)
Second-Generation Antipsychotics and Dysregulation of Glucose Metabolism: Beyond Weight Gain
Diana Grajales et al.
CELLS (2019)
Glucose metabolism dysregulation at the onset of mental illness is not limited to first episode psychosis: A systematic review and meta-analysis
Suat Kucukgoncu et al.
EARLY INTERVENTION IN PSYCHIATRY (2019)
Etiology of Metabolic Syndrome and Dietary Intervention
Hang Xu et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Oxytocin Enhancement of the Placebo Effect May Be a Novel Therapy for Working Memory Impairments
Weihua Zhao et al.
PSYCHOTHERAPY AND PSYCHOSOMATICS (2019)
Cause-specific life years lost among persons diagnosed with schizophrenia: Is it getting better or worse?
Thomas Munk Laursen et al.
SCHIZOPHRENIA RESEARCH (2019)
Adjunctive intranasal oxytocin for schizophrenia: A meta-analysis of randomized, double-blind, placebo-controlled trials
Wei Zheng et al.
SCHIZOPHRENIA RESEARCH (2019)
Meta-analysis of ghrelin alterations in schizophrenia: Effects of olanzapine
Ryan L. Goetz et al.
SCHIZOPHRENIA RESEARCH (2019)
Absence of a diurnal rhythm of oxytocin and arginine-vasopressin in human cerebrospinal fluid, blood and saliva
Simone Maria Kagerbauer et al.
NEUROPEPTIDES (2019)
The prevalence of food addiction and its associations with plasma oxytocin level and anthropometric and dietary measurements in Iranian women with obesity
Seyedeh Atefeh Panahi Moghaddam et al.
PEPTIDES (2019)
Oxytocin reduces post-stress sweet snack intake in women without attenuating salivary cortisol
V. Burmester et al.
PHYSIOLOGY & BEHAVIOR (2019)
Co-shared genetics and possible risk gene pathway partially explain the comorbidity of schizophrenia, major depressive disorder, type 2 diabetes, and metabolic syndrome
Teodor T. Postolache et al.
AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS (2019)
The OXTR Polymorphism Stratified the Correlation of Oxytocin and Glucose Homeostasis in Non-Diabetic Subjects
Hui Hua Chang et al.
DIABETES METABOLIC SYNDROME AND OBESITY-TARGETS AND THERAPY (2019)
The association between hormones and antipsychotic use: a focus on postpartum and menopausal women
Alexandre Gonzalez-Rodriguez et al.
THERAPEUTIC ADVANCES IN PSYCHOPHARMACOLOGY (2019)
Vascular RAGE transports oxytocin into the brain to elicit its maternal bonding behaviour in mice
Yasuhiko Yamamoto et al.
COMMUNICATIONS BIOLOGY (2019)
Antipsychotic treatment is associated with inflammatory and metabolic biomarkers alterations among first-episode psychosis patients: A 7-month follow-up study
Roman Balotsev et al.
EARLY INTERVENTION IN PSYCHIATRY (2019)
Endogenous Oxytocin Levels in Relation to Food Intake, Menstrual Phase, and Age in Females
Anna Aulinas et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2019)
The Lancet Psychiatry Commission: a blueprint for protecting physical health in people with mental illness
Joseph Firth et al.
LANCET PSYCHIATRY (2019)
Effects of Intranasal Oxytocin on the Blood Oxygenation Level-Dependent Signal in Food Motivation and Cognitive Control Pathways in Overweight and Obese Men
Franziska Plessow et al.
NEUROPSYCHOPHARMACOLOGY (2018)
Oxytocin and social cognition in patients with schizophrenia: comparison with healthy siblings and healthy controls
Kuzeymen Balikci et al.
PSYCHIATRY AND CLINICAL PSYCHOPHARMACOLOGY (2018)
Mortality in schizophrenia: 30-year nationwide follow-up study
A. Tanskanen et al.
ACTA PSYCHIATRICA SCANDINAVICA (2018)
Immune and metabolic alterations in first episode psychosis (FEP) patients
Luisella Bocchio-Chiavetto et al.
BRAIN BEHAVIOR AND IMMUNITY (2018)
Beyond the dopamine hypothesis of schizophrenia to three neural networks of psychosis: dopamine, serotonin, and glutamate
Stephen M. Stahl
CNS SPECTRUMS (2018)
The Global Epidemic of the Metabolic Syndrome
Mohammad G. Saklayen
CURRENT HYPERTENSION REPORTS (2018)
Effects of intranasal insulin on endogenous glucose production in insulin-resistant men
Changting Xiao et al.
DIABETES OBESITY & METABOLISM (2018)
Adipokine dysregulation and adipose tissue inflammation in human obesity
Xabier Unamuno et al.
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2018)
Haplotype analysis of endothelial nitric oxide synthase (NOS3) genetic variants and metabolic syndrome in healthy subjects and schizophrenia patients
Nikolai Fattakhov et al.
INTERNATIONAL JOURNAL OF OBESITY (2018)
Increased mortality among people with schizophrenia and other non-affective psychotic disorders in the community: A systematic review and meta-analysis
Padraig Oakley et al.
JOURNAL OF PSYCHIATRIC RESEARCH (2018)
Effects of intranasal oxytocin on satiety signaling in people with schizophrenia
Kimberly R. Warren et al.
PHYSIOLOGY & BEHAVIOR (2018)
An association between the BanI polymorphism of the PLA2G4A gene for calcium-dependent phospholipase A2 and plasma glucose levels among females with schizophrenia
Sergej Nadalin et al.
PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS (2018)
Long-Term Evolution of Metabolic Status in Patients with Schizophrenia Stably Maintained on Second-Generation Antipsychotics
Seong Hoon Jeong et al.
PSYCHIATRY INVESTIGATION (2018)
Associations of oxytocin and vasopressin plasma levels with neurocognitive, social cognitive and meta cognitive function in schizophrenia
Orkun Aydin et al.
PSYCHIATRY RESEARCH (2018)
Understanding the course of persistent symptoms in schizophrenia: Longitudinal findings from the pattern study
Josep Maria Haro et al.
PSYCHIATRY RESEARCH (2018)
The effect of intranasal oxytocin on neural response to facial emotions in healthy adults as measured by functional MRI: A systematic review
John Tully et al.
PSYCHIATRY RESEARCH-NEUROIMAGING (2018)
Oxytocin curbs calorie intake via food-specific increases in the activity of brain areas that process reward and establish cognitive control
Maartje S. Spetter et al.
SCIENTIFIC REPORTS (2018)
Molecular Mechanisms of Oxytocin Signaling at the Synaptic Connection
Jan Bakos et al.
NEURAL PLASTICITY (2018)
The Associations Between Oxytocin and Trauma in Humans: A Systematic Review
Mariana Fortunata Donadon et al.
FRONTIERS IN PHARMACOLOGY (2018)
Rapid-onset anorectic effects of intranasal oxytocin in young men
Victoria Burmester et al.
APPETITE (2018)
Hyperprolactinemia and insulin resistance in drug naive patients with early onset first episode psychosis
Maria Giuseppina Petruzzelli et al.
BMC PSYCHIATRY (2018)
Antipsychotic Drugs: From Receptor-binding Profiles to Metabolic Side Effects
Spyridon Siafis et al.
CURRENT NEUROPHARMACOLOGY (2018)
Peripheral oxytocin and vasopressin modulates regional brain activity differently in men and women with schizophrenia
Leah H. Rubin et al.
SCHIZOPHRENIA RESEARCH (2018)
Peripheral oxytocin and vasopressin are associated with clinical symptom severity and cognitive functioning in midlife women with chronic schizophrenia
Leah H. Rubin et al.
SCHIZOPHRENIA RESEARCH (2018)
Management of common adverse effects of antipsychotic medications
T. Scott Stroup et al.
WORLD PSYCHIATRY (2018)
Central insulin action induces activation of paraventricular oxytocin neurons to release oxytocin into circulation
Boyang Zhang et al.
SCIENTIFIC REPORTS (2018)
Evidence for genetic contribution to the increased risk of type 2 diabetes in schizophrenia
Sophie Hackinger et al.
TRANSLATIONAL PSYCHIATRY (2018)
Plasma Oxytocin Concentration in Pre- and Postmenopausal Women: Its Relationship with Obesity, Body Composition and Metabolic Variables
Sabrina Maestrini et al.
OBESITY FACTS (2018)
Responding to challenges for people with psychotic illness: Updated evidence from the Survey of High Impact Psychosis
Vera A. Morgan et al.
AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY (2017)
Oxytocin Improves β-Cell Responsivity and Glucose Tolerance in Healthy Men
Johanna Klement et al.
DIABETES (2017)
Treatment of hyperprolactinaemia reduces total cholesterol and LDL in patients with prolactinomas
Verena Schwetz et al.
METABOLIC BRAIN DISEASE (2017)
Genome-wide association analyses of sleep disturbance traits identify new loci and highlight shared genetics with neuropsychiatric and metabolic traits
Jacqueline M. Lane et al.
NATURE GENETICS (2017)
The relationship between cognitive impairment in schizophrenia and metabolic syndrome: a systematic review and meta-analysis
E. Bora et al.
PSYCHOLOGICAL MEDICINE (2017)
A Review of the Functional and Anatomical Default Mode Network in Schizophrenia
Mao-Lin Hu et al.
NEUROSCIENCE BULLETIN (2017)
Oxytocin system dysfunction as a common mechanism underlying metabolic syndrome and psychiatric symptoms in schizophrenia and bipolar disorders
Daniel S. Quintana et al.
FRONTIERS IN NEUROENDOCRINOLOGY (2017)
New Targets for Schizophrenia Treatment beyond the Dopamine Hypothesis
Albert C. Yang et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)
Central amygdala circuits modulate food consumption through a positive-valence mechanism
Amelia M. Douglass et al.
NATURE NEUROSCIENCE (2017)
Relationship of a common OXTR gene variant to brain structure and default mode network function in healthy humans
Junping Wang et al.
NEUROIMAGE (2017)
Nicotine enhances GABAergic inhibition of oxytocin mRNA-expressing neuron in the hypothalamic paraventricular nucleus in vitro in rats
Ke-Min Zhang et al.
NEUROSCIENCE LETTERS (2017)
Stress, Cortisol, and Other Appetite-Related Hormones: Prospective Prediction of 6-Month Changes in Food Cravings and Weight
Ariana M. Chao et al.
OBESITY (2017)
The Metabolic Phenotype in Obesity: Fat Mass, Body Fat Distribution, and Adipose Tissue Function
Gijs H. Goossens
OBESITY FACTS (2017)
Gating of social reward by oxytocin in the ventral tegmental area
Lin W. Hung et al.
SCIENCE (2017)
Oxytocin - The Sweet Hormone?
Gareth Leng et al.
TRENDS IN ENDOCRINOLOGY AND METABOLISM (2017)
Excess mortality in persons with severe mental disorders: a multilevel intervention framework and priorities for clinical practice, policy and research agendas
Nancy H. Liu et al.
WORLD PSYCHIATRY (2017)
Caffeine inhibits hypothalamic A1R to excite oxytocin neuron and ameliorate dietary obesity in mice
Liufeng Wu et al.
NATURE COMMUNICATIONS (2017)
Metabolic Syndrome Prevalence by Race/Ethnicity and Sex in the United States, National Health and Nutrition Examination Survey, 1988-2012
Justin Xavier Moore et al.
PREVENTING CHRONIC DISEASE (2017)
A comparison of methods to measure central and peripheral oxytocin concentrations in human and non-human primates
Arthur Lefevre et al.
SCIENTIFIC REPORTS (2017)
Oxytocin administration suppresses hypothalamic activation in response to visual food cues
Agatha A. van der Klaauw et al.
SCIENTIFIC REPORTS (2017)
Polymorphisms of the oxytocin receptor gene and overeating: the intermediary role of endophenotypic risk factors
C. Davis et al.
NUTRITION & DIABETES (2017)
Impaired Glucose Homeostasis in First-Episode Schizophrenia A Systematic Review and Meta-analysis
Toby Pillinger et al.
JAMA PSYCHIATRY (2017)
A polygenic score for schizophrenia predicts glycemic control
Han Cao et al.
TRANSLATIONAL PSYCHIATRY (2017)
The impact of Disrupted-in-Schizophrenia 1 (DISC1) on the dopaminergic system: a systematic review
T. Dahoun et al.
TRANSLATIONAL PSYCHIATRY (2017)
Serum Irisin and Oxytocin Levels as Predictors of Metabolic Parameters in Obese Children
Cigdem Binay et al.
JOURNAL OF CLINICAL RESEARCH IN PEDIATRIC ENDOCRINOLOGY (2017)
Impact of sex, fat distribution and initial body weight on oxytocin's body weight regulation
Yuko Maejima et al.
SCIENTIFIC REPORTS (2017)
Antipsychotic-associated weight gain: management strategies and impact on treatment adherence
Madhubhashinee Dayabandara et al.
NEUROPSYCHIATRIC DISEASE AND TREATMENT (2017)
Chronic hindbrain administration of oxytocin is sufficient to elicit weight loss in diet-induced obese rats
Zachary S. Roberts et al.
AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY (2017)
Hyperinsulinemia: a Cause of Obesity?
Karel A. Erion et al.
CURRENT OBESITY REPORTS (2017)
Years of potential life lost and life expectancy in schizophrenia: a systematic review and meta-analysis
Carsten Hjorthoj et al.
LANCET PSYCHIATRY (2017)
Oxytocin neuron activation prevents hypertension that occurs with chronic intermittent hypoxia/hypercapnia in rats
Heather Jameson et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2016)
Chronic CNS oxytocin signaling preferentially induces fat loss in high-fat diet-fed rats by enhancing satiety responses and increasing lipid utilization
James E. Blevins et al.
AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY (2016)
Assembling the Puzzle: Pathways of Oxytocin Signaling in the Brain
Valery Grinevich et al.
BIOLOGICAL PSYCHIATRY (2016)
Dopamine 2 Receptor Genes Are Associated with Raised Blood Glucose in Schizophrenia
Bruce R. Lawford et al.
CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE (2016)
High serum oxytocin is associated with metabolic syndrome in older men - The MINOS study
Pawel Szulc et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2016)
Effects of Intranasal Oxytocin on Long-Term Memory in Healthy Humans: A Systematic Review
Michela Brambilla et al.
DRUG DEVELOPMENT RESEARCH (2016)
Beyond the brain: disrupted in schizophrenia 1 regulates pancreatic β-cell function via glycogen synthase kinase-3β
Agata Jurczyk et al.
FASEB JOURNAL (2016)
Oxytocin enhances cognitive control of food craving in women
Nadine Striepens et al.
HUMAN BRAIN MAPPING (2016)
Metabolic pathways in the periphery and brain: Contribution to mental disorders?
Andrzej Nagalski et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2016)
Oxytocin's inhibitory effect on food intake is stronger in obese than normal-weight men
M. Thienel et al.
INTERNATIONAL JOURNAL OF OBESITY (2016)
Prolactin levels in drug-naive patients with schizophrenia and other psychotic disorders
Petros Petrikis et al.
INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE (2016)
Desensitization of leptin receptors is coincident with the upregulation of dopamine-related genes in the prefrontal cortex of adolescent mice
Danila Del Rio et al.
NEUROREPORT (2016)
Impaired glucose tolerance in first-episode drug-naive patients with schizophrenia: relationships with clinical phenotypes and cognitive deficits
D. C. Chen et al.
PSYCHOLOGICAL MEDICINE (2016)
Are leptin levels increased among people with schizophrenia versus controls? A systematic review and comparative meta-analysis
Brendon Stubbs et al.
PSYCHONEUROENDOCRINOLOGY (2016)
Effects of positive and negative human contacts and intranasal oxytocin on cerebrospinal fluid oxytocin
Jean-Loup Rault
PSYCHONEUROENDOCRINOLOGY (2016)
Diurnal neurobiological alterations after exposure to clozapine in first-episode schizophrenia patients
Hong-Qiang Sun et al.
PSYCHONEUROENDOCRINOLOGY (2016)
Adiposity-independent hypoadiponectinemia as a potential marker of insulin resistance and inflammation in schizophrenia patients treated with second generation antipsychotics
Mamta Sapra et al.
SCHIZOPHRENIA RESEARCH (2016)
A systematic review of genetic variants associated with metabolic syndrome in patients with schizophrenia
Stefanie Malan-Mueller et al.
SCHIZOPHRENIA RESEARCH (2016)
Striatal Reward Activity and Antipsychotic-Associated Weight Change in Patients With Schizophrenia Undergoing Initial Treatment
Mette O. Nielsen et al.
JAMA PSYCHIATRY (2016)
Dopamine-prolactin pathway potentially contributes to the schizophrenia and type 2 diabetes comorbidity
C. Gragnoli et al.
TRANSLATIONAL PSYCHIATRY (2016)
The association between first-episode psychosis and abnormal glycaemic control: systematic review and meta-analysis
Benjamin Ian Perry et al.
LANCET PSYCHIATRY (2016)
Weight gain and obesity in schizophrenia: epidemiology, pathobiology, and management
P. Manu et al.
ACTA PSYCHIATRICA SCANDINAVICA (2015)
Chronic oxytocin administration inhibits food intake, increases energy expenditure, and produces weight loss in fructose-fed obese rhesus monkeys
James E. Blevins et al.
AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY (2015)
Association between genetic variation in the oxytocin receptor gene and emotional withdrawal, but not between oxytocin pathway genes and diagnosis in psychotic disorders
Marit Haram et al.
FRONTIERS IN HUMAN NEUROSCIENCE (2015)
Importance of Early Weight Changes to Predict Long-Term Weight Gain During Psychotropic Drug Treatment
Frederik Vandenberghe et al.
JOURNAL OF CLINICAL PSYCHIATRY (2015)
The Regulation of Oxytocin Receptor Gene Expression during Adipogenesis
K. J. Yi et al.
JOURNAL OF NEUROENDOCRINOLOGY (2015)
Oxytocin Reduces Caloric Intake in Men
Elizabeth A. Lawson et al.
OBESITY (2015)
Translational and therapeutic potential of oxytocin as an anti-obesity strategy: Insights from rodents, nonhuman primates and humans
James E. Blevins et al.
PHYSIOLOGY & BEHAVIOR (2015)
Cardiovascular risk factors and metabolic syndrome in people with established psychotic illnesses: baseline data from the IMPaCT randomized controlled trial
P. Gardner-Sood et al.
PSYCHOLOGICAL MEDICINE (2015)
Plasma adiponectin levels in schizophrenia and role of second-generation antipsychotics: A meta-analysis
Francesco Bartoli et al.
PSYCHONEUROENDOCRINOLOGY (2015)
The effects of a single dose of oxytocin on working memory in schizophrenia
Panayiota G. Michalopoulou et al.
SCHIZOPHRENIA RESEARCH (2015)
Effects of antipsychotics, antidepressants and mood stabilizers on risk for physical diseases in people with schizophrenia, depression and bipolar disorder
Christoph U. Correll et al.
WORLD PSYCHIATRY (2015)
Relevance of Sympathetic Nervous System Activation in Obesity and Metabolic Syndrome
Alicia A. Thorp et al.
JOURNAL OF DIABETES RESEARCH (2015)
Premature Mortality Among Adults With Schizophrenia in the United States
Mark Olfson et al.
JAMA PSYCHIATRY (2015)
Oxytocin and estrogen receptor β in the brain: an overview
Alexandra Acevedo-Rodriguez et al.
FRONTIERS IN ENDOCRINOLOGY (2015)
Chronic oxytocin administration as a treatment against impaired leptin signaling or leptin resistance in obesity
Jordi Altirriba et al.
FRONTIERS IN ENDOCRINOLOGY (2015)
A role for oxytocin in the etiology and treatment of schizophrenia
Megan Elizabeth Rich et al.
FRONTIERS IN ENDOCRINOLOGY (2015)
Metabolic syndrome in people with schizophrenia: a review
MARC DE HERT et al.
World Psychiatry (2015)
Oxytocin regulates gastrointestinal motility, inflammation, macromolecular permeability, and mucosal maintenance in mice
Martha G. Welch et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2014)
Oxytocin in the ventromedial hypothalamic nucleus reduces feeding and acutely increases energy expenditure
Emily E. Noble et al.
AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY (2014)
Excess Early Mortality in Schizophrenia
Thomas Munk Laursen et al.
ANNUAL REVIEW OF CLINICAL PSYCHOLOGY, VOL 10 (2014)
Hypothalamic ghrelin signalling mediates olanzapine-induced hyperphagia and weight gain in female rats
Qingsheng Zhang et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2014)
Decreased Circulating Levels of Oxytocin in Obesity and Newly Diagnosed Type 2 Diabetic Patients
Weiyun Qian et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2014)
Glucometabolic Hormones and Cardiovascular Risk Markers in Antipsychotic-Treated Patients
Bjorn H. Ebdrup et al.
JOURNAL OF CLINICAL PSYCHIATRY (2014)
Hypooxytocinaemia in obese Zucker rats relates to oxytocin degradation in liver and adipose tissue
Lucia Gajdosechova et al.
JOURNAL OF ENDOCRINOLOGY (2014)
Metabolic Syndrome and Its Factors Affect Cognitive Function in Chronic Schizophrenia Complicated by Metabolic Syndrome
Chenhu Li et al.
JOURNAL OF NERVOUS AND MENTAL DISEASE (2014)
Increased serum prolactin levels in drug-naive first-episode male patients with schizophrenia
Yakup Albayrak et al.
NORDIC JOURNAL OF PSYCHIATRY (2014)
Almost All Antipsychotics Result in Weight Gain: A Meta-Analysis
Maarten Bak et al.
PLOS ONE (2014)
The role of oxytocin in empathy to the pain of conflictual out-group members among patients with schizophrenia
A. Abu-Akel et al.
PSYCHOLOGICAL MEDICINE (2014)
Clozapine directly increases insulin and glucagon secretion from islets: Implications for impairment of glucose tolerance
G. C. Smith et al.
SCHIZOPHRENIA RESEARCH (2014)
Molecular pathophysiology of metabolic effects of antipsychotic medications
Jacob S. Ballon et al.
TRENDS IN ENDOCRINOLOGY AND METABOLISM (2014)
PREVALENCE OF METABOLIC SYNDROME IN PATIENTS WITH SCHIZOPHRENIA ACCORDING TO THE PRESENCE OR ABSENCE OF NEGATIVE SYMPTOMS
A. Sicras-Mainar et al.
VALUE IN HEALTH (2014)
Cardiometabolic Risk in Patients With First-Episode Schizophrenia Spectrum Disorders Baseline Results From the RAISE-ETP Study
Christoph U. Correll et al.
JAMA PSYCHIATRY (2014)
Improved Detection of Common Variants Associated with Schizophrenia by Leveraging Pleiotropy with Cardiovascular-Disease Risk Factors
Ole A. Andreassen et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2013)
Oxytocin Reduces Reward-Driven Food Intake in Humans
Volker Ott et al.
DIABETES (2013)
Nocturnal oxytocin secretion is lower in amenorrheic athletes than nonathletes and associated with bone microarchitecture and finite element analysis parameters
Elizabeth A. Lawson et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2013)
Ageing and Oxytocin: A Call for Extending Human Oxytocin Research to Ageing Populations - A Mini-Review
Renske Huffmeijer et al.
GERONTOLOGY (2013)
Leptin Activates Oxytocin Neurons of the Hypothalamic Paraventricular Nucleus in Both Control and Diet-Induced Obese Rodents
Mario Perello et al.
PLOS ONE (2013)
Treatment of Obesity and Diabetes Using Oxytocin or Analogs in Patients and Mouse Models
Hai Zhang et al.
PLOS ONE (2013)
Association study of NRXN3 polymorphisms with schizophrenia and risperidone-induced bodyweight gain in Chinese Han population
Xiaofeng Hu et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2013)
The role of ghrelin signalling in second-generation antipsychotic-induced weight gain
Qingsheng Zhang et al.
PSYCHONEUROENDOCRINOLOGY (2013)
Schizophrenia: Metabolic aspects of aetiology, diagnosis and future treatment strategies
Laura W. Harris et al.
PSYCHONEUROENDOCRINOLOGY (2013)
Prevalence of Metabolic Syndrome and Metabolic Abnormalities in Schizophrenia and Related Disorders-A Systematic Review and Meta-Analysis
Alex J. Mitchell et al.
SCHIZOPHRENIA BULLETIN (2013)
Elevated levels of adiponectin and other cytokines in drug naive, first episode schizophrenia patients with normal weight
Xueqin Song et al.
SCHIZOPHRENIA RESEARCH (2013)
Peripheral vasopressin but not oxytocin relates to severity of acute psychosis in women with acutely-ill untreated first-episode psychosis
Leah H. Rubin et al.
SCHIZOPHRENIA RESEARCH (2013)
Oxytocin and oxytocin receptor gene polymorphisms and risk for schizophrenia: A case-control study
Christiane Montag et al.
WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY (2013)
A meta-analysis of cardio-metabolic abnormalities in drug naive, first-episode and multi-episode patients with schizophrenia versus general population controls
Davy Vancampfort et al.
WORLD PSYCHIATRY (2013)
The Role of Oxytocin in Psychiatric Disorders: A Review of Biological and Therapeutic Research Findings
David M. Cochran et al.
HARVARD REVIEW OF PSYCHIATRY (2013)
A role for autonomic cardiac control in the effects of oxytocin on social behavior and psychiatric illness
Daniel S. Quintana et al.
FRONTIERS IN NEUROSCIENCE (2013)
Hyperprolactinemia in antipsychotic-naive patients with first-episode psychosis
A. Riecher-Roessler et al.
PSYCHOLOGICAL MEDICINE (2013)
Oxytocin in schizophrenia: a review of evidence for its therapeutic effects
Kai MacDonald et al.
ACTA NEUROPSYCHIATRICA (2012)
Dietary habits of patients with schizophrenia: A self-reported questionnaire survey
Agustin J. Simonelli-Munoz et al.
INTERNATIONAL JOURNAL OF MENTAL HEALTH NURSING (2012)
The acute effects of olanzapine on ghrelin secretion, CCK sensitivity, meal size, locomotor activity and body temperature
E. M. van der Zwaal et al.
INTERNATIONAL JOURNAL OF OBESITY (2012)
Potential role of prolactin in antipsychotic-mediated association of schizophrenia and type 2 diabetes
Brandon Oberweis et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2012)
Oxytocin: An Emerging Regulator of Prolactin Secretion in the Female Rat
J. E. Kennett et al.
JOURNAL OF NEUROENDOCRINOLOGY (2012)
Functional-1149 G/T Polymorphism of the Prolactin Gene in Schizophrenia
Janusz K. Rybakowski et al.
NEUROPSYCHOBIOLOGY (2012)
Possible impact of ADRB3 Trp64Arg polymorphism on BMI in patients with schizophrenia
Daimei Sasayama et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2012)
Utilization of General and Specialized Cardiac Care by People With Schizophrenia
Lauren C. Bresee et al.
PSYCHIATRIC SERVICES (2012)
Oxytocin receptor (OXTR) gene and risk of schizophrenia: Case-control and family-based analyses and meta-analysis in a Japanese population
Yuichiro Watanabe et al.
PSYCHIATRY AND CLINICAL NEUROSCIENCES (2012)
Prolactin concentrations in newly diagnosed, antipsychotic-naive patients with nonaffective psychosis
Clemente Garcia-Rizo et al.
SCHIZOPHRENIA RESEARCH (2012)
At-Risk Variant in TCF7L2 for Type II Diabetes Increases Risk of Schizophrenia
Thomas Hansen et al.
BIOLOGICAL PSYCHIATRY (2011)
Oxytocin increases autonomic cardiac control: Moderation by loneliness
Greg J. Norman et al.
BIOLOGICAL PSYCHOLOGY (2011)
Polymorphisms of INSIG2, MC4R, and LEP Are Associated With Obesity- and Metabolic-Related Traits in Schizophrenic Patients
Po-Hsiu Kuo et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2011)
A review of safety, side-effects and subjective reactions to intranasal oxytocin in human research
Elayne MacDonald et al.
PSYCHONEUROENDOCRINOLOGY (2011)
Oxytocin, Dopamine, and the Amygdala: A Neurofunctional Model of Social Cognitive Deficits in Schizophrenia
Andrew J. Rosenfeld et al.
SCHIZOPHRENIA BULLETIN (2011)
Narrative Review: The Role of Leptin in Human Physiology: Emerging Clinical Applications
Theodore Kelesidis et al.
ANNALS OF INTERNAL MEDICINE (2010)
Plasma orexin A, ghrelin, cholecystokinin, visfatin, leptin and agouti-related protein levels during 6-week olanzapine treatment in first-episode male patients with psychosis
Cengiz Basoglu et al.
INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY (2010)
Schizophrenia severity and clozapine treatment outcome association with oxytocinergic genes
Renan P. Souza et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2010)
Association Between Symptom Improvement and Change of Body Mass Index, Lipid Profile, and Leptin, Ghrelin, and Cholecystokinin Levels During 6-Week Olanzapine Treatment in Patients With First-Episode Psychosis
Cengiz Basoglu et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2010)
Association study of polymorphisms in cholecystokinin gene and its receptors with antipsychotic induced weight gain in schizophrenia patients
Arun K. Tiwari et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2010)
Insulin resistance and metabolic profile in antipsychotic naive schizophrenia patients
Anindya Dasgupta et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2010)
Head-to-head comparisons of metabolic side effects of second generation antipsychotics in the treatment of schizophrenia: A systematic review and meta-analysis
Christine Rummel-Kluge et al.
SCHIZOPHRENIA RESEARCH (2010)
Effect of antipsychotic treatment on Insulin-like Growth Factor-1 and cortisol in schizophrenia: A longitudinal study
Ganesan Venkatasubramanian et al.
SCHIZOPHRENIA RESEARCH (2010)
Rethinking the genetic basis for comorbidity of schizophrenia and type 2 diabetes
P. I. Lin et al.
SCHIZOPHRENIA RESEARCH (2010)
Intranasal Oxytocin Increases Positive Communication and Reduces Cortisol Levels During Couple Conflict
Beate Ditzen et al.
BIOLOGICAL PSYCHIATRY (2009)
Metabolic profile of antipsychotic-naive individuals with non-affective psychosis
Emilio Fernandez-Egea et al.
BRITISH JOURNAL OF PSYCHIATRY (2009)
Low Sympathetic Tone and Obese Phenotype in Oxytocin-deficient Mice
Claudia Camerino
OBESITY (2009)
Sharing secrets: Oxytocin and trust in schizophrenia
Szabolcs Keri et al.
SOCIAL NEUROSCIENCE (2009)
Schizophrenia: A Concise Overview of Incidence, Prevalence, and Mortality
John McGrath et al.
EPIDEMIOLOGIC REVIEWS (2008)
Involvement of cholecystokinin receptor in the inhibition of gastrointestinal motility by oxytocin in ovariectomized rats
Chiu-Lung Wu et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2008)
Hepatic insulin resistance in antipsychotic naive schizophrenic patients: Stable isotope studies of glucose metabolism
Lonneke J. M. van Nimwegen et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2008)
Oxytocin receptor-deficient mice developed late-onset obesity
Yuki Takayanagi et al.
NEUROREPORT (2008)
Early treatment-related changes in diabetes and cardiovascular disease risk markers in first episode psychosis subjects
Karen A. Graham et al.
SCHIZOPHRENIA RESEARCH (2008)
Impaired glucose tolerance in first-episode drug-naive patients with schizophrenia
L. M. Spelman et al.
DIABETIC MEDICINE (2007)
Changes in neuroendocrine and metabolic hormones induced by atypical antipsychotics in normal-weight patients with schizophrenia
Vera Popovic et al.
NEUROENDOCRINOLOGY (2007)
The role of leptin and ghrelin in the regulation of food intake and body weight in humans: A review
M. D. Klok et al.
OBESITY REVIEWS (2007)
Leptin receptor signaling in midbrain dopamine neurons regulates feeding
Jonathan D. Hommel et al.
NEURON (2006)
Insulin resistance and adiponectin levels in drug-free patients with schizophrenia: A preliminary report
Tony A. Cohn et al.
CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE (2006)
Clinical value of the metabolic syndrome for long term prediction of total and cardiovascular mortality:: prospective, population based cohort study
J Sundström et al.
BMJ-BRITISH MEDICAL JOURNAL (2006)
The association among autonomic nervous system function, incident diabetes, and intervention arm in the diabetes prevention program
MR Carnethon et al.
DIABETES CARE (2006)
Schizophrenia, antipsychotics and diabetes: genetic aspects
F Bellivier
EUROPEAN PSYCHIATRY (2005)
Evidence of basal pituitary-ad renal overactivity in first episode, drug naive patients with schizophrenia
MCM Ryan et al.
PSYCHONEUROENDOCRINOLOGY (2004)
Association between a novel polymorphism in the promoter region of the neuropeptide Y gene and schizophrenia in humans
M Itokawa et al.
NEUROSCIENCE LETTERS (2003)
Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III)
JI Cleeman et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2001)
The Oxytocin Receptor System: Structure, function, and regulation
G Gimpl et al.
PHYSIOLOGICAL REVIEWS (2001)
Share Paper
